Focused on use of synthetic biology techniques to engineer mammalian cells for a wide variety of applications.

Sectors
Healthcare
Life Sciences
First Invested
2016
Early
Company Status
IPO/Public
NASDAQ: SNTI
Dynamics Special Purpose Corp.
Board Members
Edward Mathers